'Tis in our nature: taking the human-cannabis relationship seriously in health science and public policy.
作者信息
Aggarwal Sunil K
机构信息
Department of Rehabilitation Medicine, New York University School of Medicine New York, NY, USA.
出版信息
Front Psychiatry. 2013 Feb 26;4:6. doi: 10.3389/fpsyt.2013.00006. eCollection 2013.
Abstract
摘要
相似文献
1
'Tis in our nature: taking the human-cannabis relationship seriously in health science and public policy.这是我们的天性：在健康科学和公共政策中认真对待人类与大麻的关系。
Front Psychiatry. 2013 Feb 26;4:6. doi: 10.3389/fpsyt.2013.00006. eCollection 2013.
2
Observations of the role of science in the United States medical cannabis state policies: Lessons learnt.美国医用大麻州政策中科学作用的观察：经验教训
Int J Drug Policy. 2017 Apr;42:109-114. doi: 10.1016/j.drugpo.2016.12.019. Epub 2017 Feb 9.
3
Six policy lessons relevant to cannabis legalization.与大麻合法化相关的六条政策经验教训。
Am J Drug Alcohol Abuse. 2019;45(6):698-706. doi: 10.1080/00952990.2019.1569669. Epub 2019 Mar 14.
4
CANNABIS LEGALIZATION IN STATE LEGISLATURES: PUBLIC HEALTH OPPORTUNITY AND RISK.州立法机构中的大麻合法化：公共卫生机遇与风险。
Marquette Law Rev. 2020 Summer;103(4):1313-1400.
5
Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.评估加拿大大麻合法化对公共卫生的影响：监测和评估的“指标”核心结果指标。
J Public Health (Oxf). 2019 Jun 1;41(2):412-421. doi: 10.1093/pubmed/fdy090.
6
Cannabis Legalization in Canada: Reflections on Public Health and the Governance of Legal Psychoactive Substances.加拿大的大麻合法化：对公共卫生及合法精神活性物质管理的思考
Front Public Health. 2018 Aug 6;6:220. doi: 10.3389/fpubh.2018.00220. eCollection 2018.
7
Prohibition, regulation or laissez faire: The policy trade-offs of cannabis policy.禁止、管制还是放任自流：大麻政策的政策权衡。
Int J Drug Policy. 2018 Jun;56:153-161. doi: 10.1016/j.drugpo.2018.03.024. Epub 2018 Apr 7.
8
The New Cannabis Policy Taxonomy on APIS: Making Sense of the Cannabis Policy Universe.《应用政策信息系统（APIS）上的新型大麻政策分类法：解读大麻政策领域》
J Prim Prev. 2017 Jun;38(3):295-314. doi: 10.1007/s10935-017-0475-6.
9
The Increasing Use of Cannabis Among Older Americans: A Public Health Crisis or Viable Policy Alternative?美国老年人中越来越多的人使用大麻：是公共卫生危机还是可行的政策选择？
Gerontologist. 2017 Nov 10;57(6):1166-1172. doi: 10.1093/geront/gnw166.
10
What are the policy implications of the evidence on cannabis and psychosis?关于大麻与精神病的证据有哪些政策含义？
Can J Psychiatry. 2006 Aug;51(9):566-74. doi: 10.1177/070674370605100904.
引用本文的文献
1
Use of cannabinoids in cancer care: palliative care.大麻素在癌症护理中的应用：姑息治疗。
Curr Oncol. 2016 Mar;23(2):S33-6. doi: 10.3747/co.23.2962. Epub 2016 Mar 16.
2
Clearing the smokescreen: the current evidence on cannabis use.拨开迷雾：关于大麻使用的当前证据
Front Psychiatry. 2015 Mar 13;6:40. doi: 10.3389/fpsyt.2015.00040. eCollection 2015.
本文引用的文献
1
Medical marijuana: clearing away the smoke.医用大麻：拨开迷雾。
Open Neurol J. 2012;6:18-25. doi: 10.2174/1874205X01206010018. Epub 2012 May 4.
2
Psychoactive substances and the political ecology of mental distress.精神活性物质与精神困扰的政治生态
Harm Reduct J. 2012 Jan 18;9:4. doi: 10.1186/1477-7517-9-4.
3
Phytochemical and genetic analyses of ancient cannabis from Central Asia.对中亚古代大麻的植物化学和基因分析。
J Exp Bot. 2008;59(15):4171-82. doi: 10.1093/jxb/ern260.
4
Here, there and everywhere: the endocannabinoid system.无处不在：内源性大麻素系统。
J Neuroendocrinol. 2008 May;20 Suppl 1:iv-vi. doi: 10.1111/j.1365-2826.2008.01691.x.
5
History of cannabis and its preparations in saga, science, and sobriquet.传奇、科学及别名中的大麻及其制剂史。
Chem Biodivers. 2007 Aug;4(8):1614-48. doi: 10.1002/cbdv.200790144.
6
The endocannabinoid system as an emerging target of pharmacotherapy.内源性大麻素系统作为药物治疗的一个新兴靶点。
Pharmacol Rev. 2006 Sep;58(3):389-462. doi: 10.1124/pr.58.3.2.
7
Harm reduction--the cannabis paradox.减少危害——大麻悖论。
Harm Reduct J. 2005 Sep 22;2:17. doi: 10.1186/1477-7517-2-17.
Zotero 插件